Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults
Clinical trial NCT00472719 · COMPLETED
Trial details
- NCT number
- NCT00472719
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2008-07-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.